nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—schizophrenia	0.686	1	CbGaD
Suramin—F2—urine—schizophrenia	0.0054	0.0441	CbGeAlD
Suramin—FSHR—gonad—schizophrenia	0.00412	0.0336	CbGeAlD
Suramin—P2RY2—blood—schizophrenia	0.00382	0.0311	CbGeAlD
Suramin—PLA2G2A—blood plasma—schizophrenia	0.00374	0.0305	CbGeAlD
Suramin—SIRT5—forebrain—schizophrenia	0.00353	0.0288	CbGeAlD
Suramin—P2RY2—endocrine gland—schizophrenia	0.00331	0.027	CbGeAlD
Suramin—SIRT5—telencephalon—schizophrenia	0.00324	0.0264	CbGeAlD
Suramin—FSHR—endocrine gland—schizophrenia	0.00311	0.0254	CbGeAlD
Suramin—SIRT1—forebrain—schizophrenia	0.00292	0.0238	CbGeAlD
Suramin—F2—blood plasma—schizophrenia	0.00282	0.023	CbGeAlD
Suramin—FSHR—cerebellum—schizophrenia	0.00274	0.0224	CbGeAlD
Suramin—SIRT5—gonad—schizophrenia	0.00271	0.0221	CbGeAlD
Suramin—SIRT1—telencephalon—schizophrenia	0.00269	0.0219	CbGeAlD
Suramin—PLA2G4A—blood plasma—schizophrenia	0.0026	0.0212	CbGeAlD
Suramin—SIRT5—blood—schizophrenia	0.00236	0.0192	CbGeAlD
Suramin—SIRT1—gonad—schizophrenia	0.00224	0.0183	CbGeAlD
Suramin—P2RX4—blood—schizophrenia	0.00223	0.0182	CbGeAlD
Suramin—ARSA—gonad—schizophrenia	0.00222	0.0181	CbGeAlD
Suramin—SIRT5—endocrine gland—schizophrenia	0.00205	0.0167	CbGeAlD
Suramin—SIRT1—blood—schizophrenia	0.00195	0.0159	CbGeAlD
Suramin—P2RX4—endocrine gland—schizophrenia	0.00193	0.0158	CbGeAlD
Suramin—ARSA—blood—schizophrenia	0.00193	0.0157	CbGeAlD
Suramin—SIRT1—midbrain—schizophrenia	0.00193	0.0157	CbGeAlD
Suramin—SIRT5—nervous system—schizophrenia	0.00191	0.0156	CbGeAlD
Suramin—PLA2G2A—telencephalon—schizophrenia	0.00188	0.0153	CbGeAlD
Suramin—SIRT5—central nervous system—schizophrenia	0.00184	0.015	CbGeAlD
Suramin—P2RX4—nervous system—schizophrenia	0.00181	0.0148	CbGeAlD
Suramin—RYR1—blood—schizophrenia	0.00181	0.0147	CbGeAlD
Suramin—SIRT5—cerebellum—schizophrenia	0.0018	0.0147	CbGeAlD
Suramin—RYR1—midbrain—schizophrenia	0.00178	0.0145	CbGeAlD
Suramin—P2RX4—central nervous system—schizophrenia	0.00174	0.0142	CbGeAlD
Suramin—P2RX4—cerebellum—schizophrenia	0.0017	0.0139	CbGeAlD
Suramin—SIRT1—endocrine gland—schizophrenia	0.0017	0.0138	CbGeAlD
Suramin—ARSA—endocrine gland—schizophrenia	0.00167	0.0137	CbGeAlD
Suramin—SIRT1—nervous system—schizophrenia	0.00159	0.0129	CbGeAlD
Suramin—ARSA—nervous system—schizophrenia	0.00157	0.0128	CbGeAlD
Suramin—RYR1—endocrine gland—schizophrenia	0.00157	0.0128	CbGeAlD
Suramin—SIRT1—central nervous system—schizophrenia	0.00153	0.0125	CbGeAlD
Suramin—ARSA—central nervous system—schizophrenia	0.00151	0.0123	CbGeAlD
Suramin—SIRT1—cerebellum—schizophrenia	0.00149	0.0122	CbGeAlD
Suramin—ARSA—cerebellum—schizophrenia	0.00147	0.012	CbGeAlD
Suramin—RYR1—nervous system—schizophrenia	0.00147	0.012	CbGeAlD
Suramin—SIRT5—brain—schizophrenia	0.00146	0.0119	CbGeAlD
Suramin—RYR1—central nervous system—schizophrenia	0.00141	0.0115	CbGeAlD
Suramin—P2RX4—brain—schizophrenia	0.00138	0.0113	CbGeAlD
Suramin—RYR1—cerebellum—schizophrenia	0.00138	0.0112	CbGeAlD
Suramin—PLA2G2A—blood—schizophrenia	0.00137	0.0112	CbGeAlD
Suramin—PLA2G2A—midbrain—schizophrenia	0.00135	0.011	CbGeAlD
Suramin—SIRT1—brain—schizophrenia	0.00121	0.00989	CbGeAlD
Suramin—ARSA—brain—schizophrenia	0.0012	0.00977	CbGeAlD
Suramin—PLA2G2A—endocrine gland—schizophrenia	0.00119	0.00968	CbGeAlD
Suramin—RYR1—brain—schizophrenia	0.00112	0.00914	CbGeAlD
Suramin—PLA2G2A—nervous system—schizophrenia	0.00111	0.00906	CbGeAlD
Suramin—PLA2G2A—central nervous system—schizophrenia	0.00107	0.00872	CbGeAlD
Suramin—F2—blood—schizophrenia	0.00103	0.00843	CbGeAlD
Suramin—PLA2G4A—blood—schizophrenia	0.000952	0.00776	CbGeAlD
Suramin—PLA2G4A—midbrain—schizophrenia	0.00094	0.00766	CbGeAlD
Suramin—F2—endocrine gland—schizophrenia	0.000896	0.00731	CbGeAlD
Suramin—PLA2G2A—brain—schizophrenia	0.000849	0.00692	CbGeAlD
Suramin—F2—nervous system—schizophrenia	0.000839	0.00684	CbGeAlD
Suramin—PLA2G4A—endocrine gland—schizophrenia	0.000825	0.00673	CbGeAlD
Suramin—F2—central nervous system—schizophrenia	0.000808	0.00658	CbGeAlD
Suramin—PLA2G4A—nervous system—schizophrenia	0.000772	0.0063	CbGeAlD
Suramin—PLA2G4A—central nervous system—schizophrenia	0.000744	0.00606	CbGeAlD
Suramin—F2—brain—schizophrenia	0.000641	0.00523	CbGeAlD
Suramin—PLA2G4A—brain—schizophrenia	0.00059	0.00481	CbGeAlD
Suramin—FSHR—Signaling Pathways—YWHAZ—schizophrenia	3.76e-05	0.000196	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FZD3—schizophrenia	3.72e-05	0.000194	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GRM5—schizophrenia	3.71e-05	0.000194	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCK—schizophrenia	3.71e-05	0.000194	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ERBB3—schizophrenia	3.68e-05	0.000192	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HTR2A—schizophrenia	3.66e-05	0.000191	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PPP1R1B—schizophrenia	3.66e-05	0.000191	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—ACE—schizophrenia	3.63e-05	0.00019	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PDE4B—schizophrenia	3.61e-05	0.000189	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—CYP1A2—schizophrenia	3.58e-05	0.000187	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCKAR—schizophrenia	3.55e-05	0.000186	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—NPY—schizophrenia	3.55e-05	0.000185	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HTR2A—schizophrenia	3.54e-05	0.000185	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TH—schizophrenia	3.53e-05	0.000184	CbGpPWpGaD
Suramin—ARSA—Metabolism—APOE—schizophrenia	3.51e-05	0.000183	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FES—schizophrenia	3.49e-05	0.000182	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PPP3CC—schizophrenia	3.49e-05	0.000182	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM2—schizophrenia	3.49e-05	0.000182	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TAAR6—schizophrenia	3.49e-05	0.000182	CbGpPWpGaD
Suramin—F2—Hemostasis—PLA2G4A—schizophrenia	3.49e-05	0.000182	CbGpPWpGaD
Suramin—ARSA—Metabolism—APOA1—schizophrenia	3.47e-05	0.000181	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP26B1—schizophrenia	3.46e-05	0.000181	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—HTR2A—schizophrenia	3.45e-05	0.00018	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—ADORA2A—schizophrenia	3.45e-05	0.00018	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR1B—schizophrenia	3.42e-05	0.000179	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—OXT—schizophrenia	3.42e-05	0.000179	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APOE—schizophrenia	3.4e-05	0.000178	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FZD3—schizophrenia	3.4e-05	0.000178	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCK—schizophrenia	3.39e-05	0.000177	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APOA1—schizophrenia	3.37e-05	0.000176	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PDE4B—schizophrenia	3.3e-05	0.000173	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR1A—schizophrenia	3.29e-05	0.000172	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APOE—schizophrenia	3.29e-05	0.000172	CbGpPWpGaD
Suramin—F2—Hemostasis—YWHAZ—schizophrenia	3.28e-05	0.000171	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	3.26e-05	0.00017	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—ESR1—schizophrenia	3.25e-05	0.00017	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APOA1—schizophrenia	3.25e-05	0.00017	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCKAR—schizophrenia	3.25e-05	0.00017	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—NPS—schizophrenia	3.24e-05	0.000169	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NGEF—schizophrenia	3.23e-05	0.000169	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NPY—schizophrenia	3.22e-05	0.000168	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM2—schizophrenia	3.2e-05	0.000167	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TAAR6—schizophrenia	3.2e-05	0.000167	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FES—schizophrenia	3.2e-05	0.000167	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PPP3CC—schizophrenia	3.2e-05	0.000167	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2C—schizophrenia	3.18e-05	0.000166	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD1—schizophrenia	3.18e-05	0.000166	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NTS—schizophrenia	3.16e-05	0.000165	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—ADORA2A—schizophrenia	3.15e-05	0.000165	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—ESR1—schizophrenia	3.14e-05	0.000164	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR1B—schizophrenia	3.11e-05	0.000162	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—OXT—schizophrenia	3.11e-05	0.000162	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD3—schizophrenia	3.08e-05	0.000161	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GCLM—schizophrenia	3.08e-05	0.000161	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPH1—schizophrenia	3.08e-05	0.000161	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—COMT—schizophrenia	3e-05	0.000157	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—YWHAZ—schizophrenia	3e-05	0.000157	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR1A—schizophrenia	2.99e-05	0.000156	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD4—schizophrenia	2.99e-05	0.000156	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTP1—schizophrenia	2.99e-05	0.000156	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MAOA—schizophrenia	2.98e-05	0.000156	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RGS4—schizophrenia	2.97e-05	0.000155	CbGpPWpGaD
Suramin—F2—Signaling Pathways—RTN4—schizophrenia	2.97e-05	0.000155	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM3—schizophrenia	2.97e-05	0.000155	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NGEF—schizophrenia	2.96e-05	0.000154	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—GSK3B—schizophrenia	2.95e-05	0.000154	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NPY—schizophrenia	2.94e-05	0.000154	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NPS—schizophrenia	2.94e-05	0.000154	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR6—schizophrenia	2.92e-05	0.000152	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PRKD1—schizophrenia	2.9e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.89e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NTS—schizophrenia	2.89e-05	0.000151	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2C—schizophrenia	2.89e-05	0.000151	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD1—schizophrenia	2.89e-05	0.000151	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CNR1—schizophrenia	2.86e-05	0.000149	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—GSK3B—schizophrenia	2.85e-05	0.000149	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—OXT—schizophrenia	2.84e-05	0.000148	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR1B—schizophrenia	2.84e-05	0.000148	CbGpPWpGaD
Suramin—F2—Hemostasis—APOA1—schizophrenia	2.84e-05	0.000148	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ABCB1—schizophrenia	2.83e-05	0.000148	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MAG—schizophrenia	2.82e-05	0.000147	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD3—schizophrenia	2.8e-05	0.000146	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR7—schizophrenia	2.79e-05	0.000145	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—DRD2—schizophrenia	2.79e-05	0.000145	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PLA2G4A—schizophrenia	2.75e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—GSTM1—schizophrenia	2.75e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR1A—schizophrenia	2.73e-05	0.000143	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RTN4—schizophrenia	2.72e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM3—schizophrenia	2.72e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—RGS4—schizophrenia	2.72e-05	0.000142	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD4—schizophrenia	2.72e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NPS—schizophrenia	2.69e-05	0.000141	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR6—schizophrenia	2.67e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.65e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2C—schizophrenia	2.64e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD1—schizophrenia	2.64e-05	0.000138	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—APOA1—schizophrenia	2.59e-05	0.000136	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CNR1—schizophrenia	2.59e-05	0.000135	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CHRM1—schizophrenia	2.58e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MAG—schizophrenia	2.58e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD3—schizophrenia	2.56e-05	0.000134	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR7—schizophrenia	2.53e-05	0.000132	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—DRD2—schizophrenia	2.53e-05	0.000132	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IL3RA—schizophrenia	2.51e-05	0.000131	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD4—schizophrenia	2.48e-05	0.00013	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TLE1—schizophrenia	2.45e-05	0.000128	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRG3—schizophrenia	2.45e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—MTHFR—schizophrenia	2.43e-05	0.000127	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GFAP—schizophrenia	2.42e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GAPDH—schizophrenia	2.42e-05	0.000126	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CLOCK—schizophrenia	2.4e-05	0.000125	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GRM5—schizophrenia	2.39e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.39e-05	0.000125	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CNR1—schizophrenia	2.37e-05	0.000124	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.36e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CHRM1—schizophrenia	2.36e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TPH2—schizophrenia	2.33e-05	0.000122	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CACNB2—schizophrenia	2.33e-05	0.000122	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.33e-05	0.000122	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TLE3—schizophrenia	2.32e-05	0.000121	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—DRD2—schizophrenia	2.31e-05	0.000121	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR7—schizophrenia	2.31e-05	0.000121	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DPYD—schizophrenia	2.3e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IL3RA—schizophrenia	2.3e-05	0.00012	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—schizophrenia	2.26e-05	0.000118	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRG3—schizophrenia	2.24e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TLE1—schizophrenia	2.24e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOA1—schizophrenia	2.23e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GFAP—schizophrenia	2.21e-05	0.000116	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCK—schizophrenia	2.19e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GRM5—schizophrenia	2.19e-05	0.000114	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKT1—schizophrenia	2.19e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CACNA1C—schizophrenia	2.13e-05	0.000112	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PDE4B—schizophrenia	2.13e-05	0.000111	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TLE3—schizophrenia	2.12e-05	0.000111	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKT1—schizophrenia	2.11e-05	0.00011	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCKAR—schizophrenia	2.1e-05	0.00011	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3C2A—schizophrenia	2.08e-05	0.000109	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ADORA2A—schizophrenia	2.04e-05	0.000106	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCK—schizophrenia	2e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PLA2G4A—schizophrenia	2e-05	0.000105	CbGpPWpGaD
Suramin—ARSA—Metabolism—EP300—schizophrenia	2e-05	0.000104	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKT1—schizophrenia	1.98e-05	0.000104	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.97e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PDE4B—schizophrenia	1.95e-05	0.000102	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGA—schizophrenia	1.95e-05	0.000102	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—HTR2A—schizophrenia	1.95e-05	0.000102	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EP300—schizophrenia	1.94e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCKAR—schizophrenia	1.92e-05	0.0001	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—AKT1—schizophrenia	1.92e-05	0.0001	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKT1—schizophrenia	1.92e-05	0.0001	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NPY—schizophrenia	1.9e-05	9.94e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH4—schizophrenia	1.9e-05	9.94e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ATP2A2—schizophrenia	1.9e-05	9.94e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EP300—schizophrenia	1.87e-05	9.79e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP2D6—schizophrenia	1.87e-05	9.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SNAP25—schizophrenia	1.87e-05	9.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ADORA2A—schizophrenia	1.86e-05	9.73e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR1B—schizophrenia	1.84e-05	9.59e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—OXT—schizophrenia	1.84e-05	9.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGA—schizophrenia	1.79e-05	9.32e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HTR2A—schizophrenia	1.77e-05	9.25e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR1A—schizophrenia	1.77e-05	9.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—schizophrenia	1.75e-05	9.16e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NPS—schizophrenia	1.74e-05	9.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ATP2A2—schizophrenia	1.74e-05	9.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NPY—schizophrenia	1.74e-05	9.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH4—schizophrenia	1.74e-05	9.09e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2C—schizophrenia	1.71e-05	8.91e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD1—schizophrenia	1.71e-05	8.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CYP1A2—schizophrenia	1.69e-05	8.82e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR1B—schizophrenia	1.68e-05	8.77e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—OXT—schizophrenia	1.68e-05	8.77e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TH—schizophrenia	1.66e-05	8.69e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NTRK2—schizophrenia	1.66e-05	8.67e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD3—schizophrenia	1.65e-05	8.63e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—EP300—schizophrenia	1.64e-05	8.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HTR2A—schizophrenia	1.62e-05	8.46e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR1A—schizophrenia	1.62e-05	8.44e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD4—schizophrenia	1.6e-05	8.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NPS—schizophrenia	1.59e-05	8.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD1—schizophrenia	1.56e-05	8.15e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2C—schizophrenia	1.56e-05	8.15e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR1—schizophrenia	1.53e-05	8e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NTRK2—schizophrenia	1.52e-05	7.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD3—schizophrenia	1.51e-05	7.89e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—EP300—schizophrenia	1.5e-05	7.81e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR7—schizophrenia	1.49e-05	7.81e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DRD2—schizophrenia	1.49e-05	7.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD4—schizophrenia	1.47e-05	7.66e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—COMT—schizophrenia	1.41e-05	7.39e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PRL—schizophrenia	1.41e-05	7.37e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTP1—schizophrenia	1.41e-05	7.35e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MAOA—schizophrenia	1.4e-05	7.34e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR1—schizophrenia	1.4e-05	7.32e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—AKT1—schizophrenia	1.39e-05	7.27e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—schizophrenia	1.39e-05	7.25e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR7—schizophrenia	1.37e-05	7.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DRD2—schizophrenia	1.37e-05	7.14e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.36e-05	7.11e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—schizophrenia	1.34e-05	7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCB1—schizophrenia	1.33e-05	6.96e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—S100B—schizophrenia	1.32e-05	6.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GSTM1—schizophrenia	1.29e-05	6.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PRL—schizophrenia	1.29e-05	6.74e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—EP300—schizophrenia	1.29e-05	6.72e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB4—schizophrenia	1.26e-05	6.57e-05	CbGpPWpGaD
Suramin—ARSA—Metabolism—AKT1—schizophrenia	1.21e-05	6.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—S100B—schizophrenia	1.2e-05	6.28e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PLA2G4A—schizophrenia	1.18e-05	6.18e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT1—schizophrenia	1.17e-05	6.12e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—schizophrenia	1.17e-05	6.11e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRG1—schizophrenia	1.16e-05	6.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB4—schizophrenia	1.15e-05	6.01e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MEF2C—schizophrenia	1.15e-05	6.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—MTHFR—schizophrenia	1.14e-05	5.97e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT1—schizophrenia	1.13e-05	5.92e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—YWHAZ—schizophrenia	1.11e-05	5.81e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ERBB3—schizophrenia	1.09e-05	5.68e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—schizophrenia	1.07e-05	5.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—schizophrenia	1.06e-05	5.56e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRG1—schizophrenia	1.06e-05	5.55e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MEF2C—schizophrenia	1.05e-05	5.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOA1—schizophrenia	1.05e-05	5.5e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HTR2A—schizophrenia	1.05e-05	5.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—YWHAZ—schizophrenia	1.02e-05	5.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ERBB3—schizophrenia	9.95e-06	5.19e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT1—schizophrenia	9.88e-06	5.16e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—schizophrenia	9.73e-06	5.08e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOA1—schizophrenia	9.62e-06	5.02e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HTR2A—schizophrenia	9.57e-06	5e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—ESR1—schizophrenia	9.29e-06	4.85e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT1—schizophrenia	9.04e-06	4.72e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—schizophrenia	8.9e-06	4.65e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOA1—schizophrenia	8.8e-06	4.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—ESR1—schizophrenia	8.5e-06	4.44e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GSK3B—schizophrenia	8.43e-06	4.4e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKT1—schizophrenia	7.78e-06	4.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GSK3B—schizophrenia	7.71e-06	4.03e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT1—schizophrenia	6.25e-06	3.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—EP300—schizophrenia	6.06e-06	3.17e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT1—schizophrenia	5.67e-06	2.96e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EP300—schizophrenia	5.54e-06	2.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT1—schizophrenia	5.19e-06	2.71e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EP300—schizophrenia	5.07e-06	2.65e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—schizophrenia	3.97e-06	2.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKT1—schizophrenia	3.66e-06	1.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—schizophrenia	3.63e-06	1.9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT1—schizophrenia	3.35e-06	1.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT1—schizophrenia	3.06e-06	1.6e-05	CbGpPWpGaD
